Last year, we worked closely with colleagues in the Department of Health on behalf of our member companies to ensure that patients have access to high quality healthcare, including the appropriate use of modern medicines.
One recent activity involved supporting a number of the DH National Clinical Directors, by facilitating meetings with interested member companies to look at issues of common interest, as well as finding mutually beneficial solutions to improve patient care. There are a number of active groups looking at a diverse range of topics, including: